These two disorders share many features, making proper diagnosis a challenge. Treatment providers must be aware that some ...

Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

S, Clinical Rater with BioBehavioral Research of Austin (BBRA) stopped by Studio 512 to talk about what BBRA does, and her ...

An Australian influencer who allegedly 'tortured' her 1-year-old daughter by making her sick amid a scam to get donations and ...

The U.S. Food and Drug Administration (FDA) approved the antidepressant nasal spray Spravato as a standalone treatment for depression in adults.

A brain rhythm working in tandem with the body's natural sleep-wake cycle may explain why bipolar patients alternate between ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Study published in Nature identifies nearly 300 genomic regions associated with bipolar disorder, and 36 key genes involved in the disease.